Multi-Transcriptomic Analysis and Experimental Validation Implicate a Central Role of STAT3 in Skin Barrier Dysfunction Induced Aggravation of Rosacea

References

• Gallo RL, Granstein RD, Kang S, et al. Rosacea comorbidities and future research: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78:167–170. doi:10.1016/j.jaad.2017.06.150
   PubMed Web of Science ®Google Scholar
• Li J, Wang B, Deng Y. Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study. J Dermatol. 2020;47(5):497–502. doi:10.1111/1346-8138.15301
   PubMed Web of Science ®Google Scholar
• Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018;78(1):148–155. doi:10.1016/j.jaad.2017.08.037
   PubMed Web of Science ®Google Scholar
• van Zuuren EJ, Solomon CG. Rosacea. N Engl J Med. 2017;377(18):1754–1764. doi:10.1056/NEJMcp1506630
   PubMed Web of Science ®Google Scholar
• Zuo Z, Wang B, Shen M, et al. Skincare habits and rosacea in 3439 Chinese adolescents: a University-based Cross-sectional Study. Acta Derm Venereol. 2020;100(3):adv00081–adv00085. doi:10.2340/00015555-3442
   PubMed Web of Science ®Google Scholar
• Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122(9):1285–1294. doi:10.1242/jcs.033969
   PubMed Web of Science ®Google Scholar
• Celebi Sözener Z, Cevhertas L, Nadeau K, Akdis M, Akdis CA. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020;145(6):1517–1528. doi:10.1016/j.jaci.2020.04.024
   PubMed Web of Science ®Google Scholar
• Dirschka T, Tronnier H, Fölster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150(6):1136–1141. doi:10.1111/j.1365-2133.2004.05985.x
   PubMed Web of Science ®Google Scholar
• Ni Raghallaigh S, Bender K, Lacey N, Brennan L, Powell FC. The fatty acid profile of the skin surface lipid layer in papulopustular rosacea. Br J Dermatol. 2012;166(2):279–287. doi:10.1111/j.1365-2133.2011.10662.x
   PubMed Web of Science ®Google Scholar
• Deng Z, Chen M, Xie H, et al. Claudin reduction may relate to an impaired skin barrier in rosacea. J Dermatol. 2019;46(4):314–321. doi:10.1111/1346-8138.14792
   PubMed Web of Science ®Google Scholar
• Medgyesi B, Dajnoki Z, Béke G, et al. Rosacea is characterized by a profoundly diminished skin barrier. J Invest Dermatol. 2020;140(10):1938–1950.e1935. doi:10.1016/j.jid.2020.02.025
   PubMed Web of Science ®Google Scholar
• Ravipati A, Nolan S, Alphonse M, et al. IL-6R/signal transducer and activator of transcription 3 signaling in keratinocytes rather than in T cells induces psoriasis-like dermatitis in mice. J Invest Dermatol. 2021. doi:10.1016/j.jid.2021.09.012
   PubMed Web of Science ®Google Scholar
• Dai X, Utsunomiya R, Shiraishi K, et al. Nuclear IL-33 plays an important role in IL-31‒mediated downregulation of FLG, keratin 1, and keratin 10 by regulating signal transducer and activator of transcription 3 activation in human keratinocytes. J Invest Dermatol. 2021;141(11):2646–2655.e6. doi:10.1016/j.jid.2021.05.033
   PubMed Web of Science ®Google Scholar
• Shih YH, Xu J, Kumar A, Li R, Chang ALS. Alterations of immune and keratinization gene expression in papulopustular rosacea by whole transcriptome analysis. J Invest Dermatol. 2020;140(5):1100–1103.e1104. doi:10.1016/j.jid.2019.09.021
   PubMed Web of Science ®Google Scholar
• Deng Z, Liu F, Chen M, et al. Keratinocyte-immune cell crosstalk in a STAT1-mediated pathway: novel insights into rosacea pathogenesis. Front Immunol. 2021;12:674871). doi:10.3389/fimmu.2021.674871
   PubMed Web of Science ®Google Scholar
• Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572–1573. doi:10.1093/bioinformatics/btq170
   PubMed Web of Science ®Google Scholar
• Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g: profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019;14:482–517. doi:10.1038/s41596-018-0103-9
   PubMed Web of Science ®Google Scholar
• Sun H, SY Liu, JY Zhou, et al. Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma. E Bio Med. 2020;60. doi:10.1016/j.ebiom.2020.102990
   Web of Science ®Google Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. doi:10.1186/s13059-017-1349-1
   PubMed Web of Science ®Google Scholar
• Long J, Huang S, Bai Y, et al. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis. Brief Bioinform. 2020. doi:10.1093/bib/bbaa224
   PubMed Web of Science ®Google Scholar
• Subramanian A, Narayan R, Corsello SM, et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171(6):1437–1452.e1417. doi:10.1016/j.cell.2017.10.049
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13:975–980. doi:10.1038/nm1616
   PubMed Web of Science ®Google Scholar
• Varghese F, Bukhari AB, Malhotra R, De A. IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One. 2014;9:e96801. doi:10.1371/journal.pone.0096801
   PubMed Web of Science ®Google Scholar
• Buhl T, Sulk M, Nowak P, et al. Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1/Th17 pathways. J Invest Dermatol. 2015;135(9):2198–2208. doi:10.1038/jid.2015.141
   PubMed Web of Science ®Google Scholar
• Georgala S, Katoulis AC, Kylafis GD, et al. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol. 2001;15(5):441–444. doi:10.1046/j.1468-3083.2001.00331.x
   PubMed Web of Science ®Google Scholar
• Shih YH, Xu J, Kumar A, Li R, Chang ALS. Alterations of immune and keratinization gene expression in papulopustular rosacea by whole transcriptome analysis. J Invest Dermatol. 2019;139(5):S170. doi:10.1016/j.jid.2019.09.021
   Web of Science ®Google Scholar
• Sahni DR, Feldman SR, Taylor SL. Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin Pharmacother. 2018;19(5):511–516. doi:10.1080/14656566.2018.1447562
   PubMed Web of Science ®Google Scholar
• Ojha D, Winkler CW, Leung JM, et al. Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons. Nat Microbiol. 2021;6(11):1398–1409. doi:10.1038/s41564-021-00968-y
   PubMed Web of Science ®Google Scholar
• Oyagbemi AA, Adejumobi OA, Jarikre TA, et al. Clofibrate, a Peroxisome Proliferator-Activated Receptor-Alpha (PPARα) agonist, and its molecular mechanisms of action against sodium fluoride-induced toxicity. Biol Trace Elem Res. 2022;200(3):1220–1236. doi:10.1007/s12011-021-02722-1
   PubMed Web of Science ®Google Scholar
• Saeed SI, Aklilu E, Mohammedsalih KM, et al. Antibacterial activity of ikarugamycin against intracellular staphylococcus aureus in bovine mammary epithelial cells in vitro infection model. Biology. 2021;10(10):958. doi:10.3390/biology10100958
   PubMed Web of Science ®Google Scholar
• Darlenski R, Kazandjieva J, Tsankov N, Fluhr JW. Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea. Exp Dermatol. 2013;22(1):752–753. doi:10.1111/exd.12251
   PubMed Web of Science ®Google Scholar
• Powell FC, Ni Raghallaigh S. Interventions for ‘rosacea’. Br J Dermatol. 2011;165(4):707–708. doi:10.1111/j.1365-2133.2011.10590.x
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Kanada K, Macleod DT, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol. 2011;131(3):688–697. doi:10.1038/jid.2010.351
   PubMed Web of Science ®Google Scholar
• Gomaa AH, Yaar M, Eyada MM, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol. 2007;34(10):748–753. doi:10.1111/j.1600-0560.2006.00695.x
   PubMed Web of Science ®Google Scholar
• Dajnoki Z, Béke G, Kapitány A, et al. Sebaceous gland-rich skin is characterized by TSLP expression and distinct immune surveillance which is disturbed in rosacea. J Invest Dermatol. 2017;137(5):1114–1125. doi:10.1016/j.jid.2016.12.025
   PubMed Web of Science ®Google Scholar
• Buddenkotte J, Steinhoff M. Recent advances in understanding and managing rosacea. F1000Res. 2018;7:1885. doi:10.12688/f1000research.16537.1
   Google Scholar
• Abul H, Mahmoud F, Al-Saleh Q, Khajeji M, Haines D. Profiles of activated T lymphocytes in peripheral blood of Kuwaiti psoriasis vulgaris patients. J Dermatol. 2002;29(4):202–208. doi:10.1111/j.1346-8138.2002.tb00250.x
   PubMed Web of Science ®Google Scholar
• Diani M, Galasso M, Cozzi C, et al. Blood to skin recirculation of CD4 (+) memory T cells associates with cutaneous and systemic manifestations of psoriatic disease. Clin Immunol. 2017;180:84–94. doi:10.1016/j.clim.2017.04.001
   PubMed Web of Science ®Google Scholar
• Han H, Roan F, Ziegler SF. The atopic march: current insights into skin barrier dysfunction and epithelial cell-derived cytokines. Immunol Rev. 2017;278(1):116–130. doi:10.1111/imr.12546
   PubMed Web of Science ®Google Scholar
• Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T (H) 2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976–984. doi:10.1016/j.jaci.2010.08.041
   PubMed Web of Science ®Google Scholar
• Sun S, Zhang X, Xu M, et al. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes. Cell Death Dis. 2019;10:274. doi:10.1038/s41419-019-1510-8
   PubMed Web of Science ®Google Scholar
• Fridman JS, Scherle PA, Collins R, et al. Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation. J Invest Dermatol. 2011;131(9):1838–1844. doi:10.1038/jid.2011.140
   PubMed Web of Science ®Google Scholar
• Schwartz DM, Kanno Y, Villarino A, et al. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nat Rev Drug Discov. 2017;16(12):843–862. doi:10.1038/nrd.2017.201
   PubMed Web of Science ®Google Scholar
• Tsuji G, Hashimoto-Hachiya A, Kiyomatsu-Oda M, et al. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis. Cell Death Dis. 2017;8:e2931–e2931. doi:10.1038/cddis.2017.322
   PubMed Web of Science ®Google Scholar
• Hashimoto-Hachiya A, Tsuji G, Murai M, Yan X, Furue M. Upregulation of FLG, LOR, and IVL expression by rhodiola crenulata root extract via aryl hydrocarbon receptor: differential involvement of OVOL1. Int J Mol Sci. 2018;19. doi:10.3390/ijms19061654
   Web of Science ®Google Scholar
• Tsuji G, Ito T, Chiba T, et al. The role of the OVOL1-OVOL2 axis in normal and diseased human skin. J Dermatol Sci. 2018;90(3):227–231. doi:10.1016/j.jdermsci.2018.02.005
   PubMed Web of Science ®Google Scholar
• Ryu WI, Lee H, Bae HC, et al. IL-33 down-regulates CLDN1 expression through the ERK/STAT3 pathway in keratinocytes. J Dermatol Sci. 2018;90(3):313–322. doi:10.1016/j.jdermsci.2018.02.017
   PubMed Web of Science ®Google Scholar
• Zhang H, Tang K, Wang Y, Fang R, Sun Q. Rosacea treatment: review and update. Dermatol Ther. 2021;11:13–24. doi:10.1007/s13555-020-00461-0
   PubMed Web of Science ®Google Scholar